• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低镁的NMDA受体非依赖性效应:腺苷的参与

NMDA-receptor-independent effects of low magnesium: involvement of adenosine.

作者信息

Stone T W, Connick J H, Bartrup J T

机构信息

Department of Pharmacology, University of Glasgow, Scotland, U.K.

出版信息

Brain Res. 1990 Feb 5;508(2):333-6. doi: 10.1016/0006-8993(90)90419-c.

DOI:10.1016/0006-8993(90)90419-c
PMID:2155041
Abstract

Perfusion of hippocampal slices with magnesium-free media elicits epileptiform activity attributable partly to the activity of N-methyl-D-aspartate (NMDA) receptors, but recent reports have documented an NMDA-independent enhancement of orthodromic potentials by moderate reductions in magnesium concentration. The present experiments indicate that this enhancement is comparable with that produced by perfusion with an adenosine antagonist, 8-phenyltheophylline, and that superfusion with this compound or adenosine deaminase precludes any enhancement of potential size in low magnesium solutions. The low magnesium enhancement is probably attributable to the recently described magnesium dependency of presynaptic inhibition by adenosine.

摘要

用无镁培养基灌注海马切片会引发癫痫样活动,部分归因于N-甲基-D-天冬氨酸(NMDA)受体的活性,但最近的报告记录了通过适度降低镁浓度可在不依赖NMDA的情况下增强顺向电位。目前的实验表明,这种增强与用腺苷拮抗剂8-苯基茶碱灌注所产生的增强相当,并且用该化合物或腺苷脱氨酶进行过灌注可防止在低镁溶液中电位大小的任何增强。低镁增强可能归因于最近描述的腺苷对突触前抑制的镁依赖性。

相似文献

1
NMDA-receptor-independent effects of low magnesium: involvement of adenosine.低镁的NMDA受体非依赖性效应:腺苷的参与
Brain Res. 1990 Feb 5;508(2):333-6. doi: 10.1016/0006-8993(90)90419-c.
2
The expression of N-methyl-D-aspartate-receptor-mediated component during epileptiform synaptic activity in hippocampus.海马癫痫样突触活动期间N-甲基-D-天冬氨酸受体介导成分的表达
Br J Pharmacol. 1987 Aug;91(4):815-22. doi: 10.1111/j.1476-5381.1987.tb11280.x.
3
Effects of NMDA antagonists on picrotoxin-, low Mg2+- and low Ca2+-induced epileptogenesis and on evoked changes in extracellular Na+ and Ca2+ concentrations in rat hippocampal slices.N-甲基-D-天冬氨酸(NMDA)拮抗剂对印防己毒素、低镁离子和低钙离子诱导的癫痫发生以及对大鼠海马切片细胞外钠离子和钙离子浓度诱发变化的影响。
Epilepsy Res. 1989 Nov-Dec;4(3):187-200. doi: 10.1016/0920-1211(89)90003-x.
4
A1 adenosine receptor-mediated block of epileptiform activity induced in zero magnesium in rat neocortex in vitro.A1 腺苷受体介导的对体外培养的大鼠新皮质在零镁环境下诱发的癫痫样活动的阻断作用。
Epilepsy Res. 1988 Sep-Oct;2(5):294-301. doi: 10.1016/0920-1211(88)90037-x.
5
Greater contribution of N-methyl-D-aspartic acid receptors in ventral compared to dorsal hippocampal slices in the expression and long-term maintenance of epileptiform activity.与背侧海马切片相比,N-甲基-D-天冬氨酸受体在腹侧海马切片癫痫样活动的表达和长期维持中起更大作用。
Neuroscience. 2005;135(3):765-79. doi: 10.1016/j.neuroscience.2005.06.024. Epub 2005 Sep 9.
6
Low magnesium epileptogenesis in the rat hippocampal slice: electrophysiological and pharmacological features.大鼠海马切片中的低镁致痫作用:电生理和药理学特征。
Brain Res. 1990 Mar 19;511(2):280-90. doi: 10.1016/0006-8993(90)90173-9.
7
Adenosine inhibits epileptiform activity arising in hippocampal area CA3.腺苷可抑制海马CA3区产生的癫痫样活动。
Br J Pharmacol. 1986 Apr;87(4):695-703. doi: 10.1111/j.1476-5381.1986.tb14587.x.
8
The anticonvulsant BW534U87 depresses epileptiform activity in rat hippocampal slices by an adenosine-dependent mechanism and through inhibition of voltage-gated Na+ channels.抗惊厥药物BW534U87通过腺苷依赖性机制并通过抑制电压门控性钠通道来抑制大鼠海马切片中的癫痫样活动。
Br J Pharmacol. 1999 Nov;128(5):1011-20. doi: 10.1038/sj.bjp.0702881.
9
Interactions of adenosine and magnesium on rat hippocampal slices.腺苷与镁对大鼠海马切片的相互作用。
Brain Res. 1988 Nov 1;463(2):374-9. doi: 10.1016/0006-8993(88)90413-1.
10
Antiepileptic effects of the excitatory amino acid antagonist cis-2,3 piperidine-dicarboxylic acid depend on non-N-methyl-d-aspartate receptors.兴奋性氨基酸拮抗剂顺式-2,3-哌啶二羧酸的抗癫痫作用取决于非N-甲基-D-天冬氨酸受体。
Arch Int Pharmacodyn Ther. 1989 May-Jun;299:28-34.